Company Quick10K Filing
FMC
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 133 $10,857
10-Q 2019-10-30 Quarter: 2019-09-30
10-Q 2019-07-31 Quarter: 2019-06-30
10-Q 2019-05-08 Quarter: 2019-03-31
10-K 2019-02-28 Annual: 2018-12-31
10-Q 2018-11-06 Quarter: 2018-09-30
10-Q 2018-08-02 Quarter: 2018-06-30
10-Q 2018-05-03 Quarter: 2018-03-31
10-K 2018-02-28 Annual: 2017-12-31
10-Q 2017-11-07 Quarter: 2017-09-29
10-Q 2017-08-02 Quarter: 2017-06-30
10-Q 2017-05-03 Quarter: 2017-03-31
10-K 2017-02-28 Annual: 2016-12-31
10-Q 2016-11-03 Quarter: 2016-09-30
10-Q 2016-08-03 Quarter: 2016-06-30
10-Q 2016-05-03 Quarter: 2016-03-31
10-K 2016-02-26 Annual: 2015-12-31
10-Q 2015-11-02 Quarter: 2015-09-30
10-Q 2015-08-06 Quarter: 2015-06-30
10-Q 2015-05-11 Quarter: 2015-03-31
10-K 2015-02-27 Annual: 2014-12-31
10-Q 2014-10-30 Quarter: 2014-09-30
10-Q 2014-08-01 Quarter: 2014-06-30
10-Q 2014-05-07 Quarter: 2014-03-31
10-K 2014-02-18 Annual: 2013-12-31
10-Q 2013-10-29 Quarter: 2013-09-30
10-Q 2013-07-30 Quarter: 2013-06-30
10-Q 2013-05-01 Quarter: 2013-03-31
10-K 2013-02-19 Annual: 2012-12-31
10-Q 2012-10-31 Quarter: 2012-09-30
10-Q 2012-08-01 Quarter: 2012-06-30
10-Q 2012-05-01 Quarter: 2012-03-31
10-K 2012-02-21 Annual: 2011-12-31
10-Q 2011-11-02 Quarter: 2011-09-30
10-Q 2011-08-03 Quarter: 2011-06-30
10-Q 2011-05-05 Quarter: 2011-03-31
10-K 2011-02-22 Annual: 2010-12-31
10-Q 2010-11-02 Quarter: 2010-09-30
10-Q 2010-08-04 Quarter: 2010-06-30
10-Q 2010-05-05 Quarter: 2010-03-31
10-K 2010-02-22 Annual: 2009-12-31
8-K 2019-12-19 Other Events, Exhibits
8-K 2019-12-18 Officers, Exhibits
8-K 2019-10-29 Earnings, Exhibits
8-K 2019-09-17 Enter Agreement, Off-BS Arrangement, Other Events, Exhibits
8-K 2019-08-02 Other Events, Exhibits
8-K 2019-07-30 Earnings, Exhibits
8-K 2019-05-17 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2019-05-06 Earnings, Exhibits
8-K 2019-04-30 Shareholder Vote
8-K 2019-03-22 Earnings, Exhibits
8-K 2019-03-01 M&A, Exhibits
8-K 2019-02-26 Other Events, Exhibits
8-K 2019-02-11 Suspend Trading, Other Events, Exhibits
8-K 2019-02-11 Earnings, Exhibits
8-K 2019-01-31 Earnings, Exhibits
8-K 2019-01-15 Officers, Exhibits
8-K 2018-12-03 Other Events, Exhibits
8-K 2018-11-08 Regulation FD
8-K 2018-11-05 Earnings, Exhibits
8-K 2018-10-19 Other Events
8-K 2018-10-15 Enter Agreement, Other Events, Exhibits
8-K 2018-09-28 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-08-01 Earnings, Exhibits
8-K 2018-05-21 Officers, Exhibits
8-K 2018-05-15 Officers
8-K 2018-05-02 Earnings, Exhibits
8-K 2018-04-24 Shareholder Vote
8-K 2018-03-29 Regulation FD, Exhibits
8-K 2018-03-09 Officers, Exhibits
8-K 2018-02-12 Earnings, Exhibits

FMC Financials

FMC Metrics, Comps, Filings

Annual | Quarterly

Business

We are a diversified chemical company serving agricultural, consumer and industrial markets globally with innovative solutions, applications and market-leading products. We operate in two distinct business segments: FMC Agricultural Solutions and FMC Lithium. Our FMC Agricultural Solutions segment develops, markets and sells all three major classes of crop protection chemicals: insecticides, herbicides and fungicides. These products are used in agriculture to enhance crop yield and quality by controlling a broad spectrum of insects, weeds and disease, as well as in non-agricultural markets for pest control. Our FMC Lithium segment manufactures lithium for use in a wide range of lithium products, which are used primarily in energy storage, specialty polymers and chemical synthesis application.

In March 2017, we announced our intention to separate our FMC Lithium segment (subsequently renamed Livent Corporation, or "Livent") into a publicly traded company. The initial step of the separation, the initial public offering ("IPO") of Livent, closed on October 15, 2018. In connection with the IPO, Livent had granted the underwriters an option to purchase additional shares of common stock to cover over-allotments at the IPO price, less the underwriting discount. On November 8, 2018, the underwriters exercised in full their option to purchase additional shares. After completion of the IPO and the underwriters' exercise to purchase additional shares of common stock, FMC owned 123 million shares of Livent's common stock, representing approximately 84 percent of the total outstanding shares of Livent's common stock. FMC presently intends to distribute the remaining Livent shares to FMC stockholders (the "Distribution") on March 1, 2019. We will continue to consolidate and present Livent as the FMC Lithium segment until the full separation date. At that time, results of FMC Lithium will be presented as a discontinued operation.

On March 31, 2017, we entered into a definitive Transaction Agreement (the "Transaction Agreement") with E. I. du Pont de Nemours and Company ("DuPont"). On November 1, 2017, pursuant to the terms and conditions set forth in the Transaction Agreement, we completed the acquisition of certain assets relating to DuPont's Crop Protection business and research and development organization ("DuPont Crop Protection Business") (collectively, the "DuPont Crop Protection Business Acquisition"). In connection with this transaction, we sold to DuPont our FMC Health and Nutrition segment and paid DuPont $1.2 billion in cash. Our FMC Health and Nutrition business and its results have been presented as a discontinued operation for all periods presented throughout this document.


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Annual)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
International Flavors & Fragrances (IFF) 16,398 41% 23.0 3% 13,348 7,023 4,716 1,956 361 891 20,456
Celanese (CE) 13,378 27% 9.6 11% 9,506 6,252 6,739 1,812 1,049 1,718 16,536
FMC (FMC) 10,857 45% 16.9 5% 9,824 7,061 4,653 2,083 503 787 13,305
Eastman Chemical (EMN) 10,762 24% 9.4 6% 16,256 10,310 9,666 2,357 915 1,724 16,200
Westlake Chemical (WLK) 8,701 18% 6.7 5% 12,216 5,957 8,419 1,532 660 1,640 10,985
Albemarle (ALB) 7,392 35% 9.7 7% 8,094 4,294 3,417 1,210 600 914 8,883
Hexcel (HXL) 6,722 27% 16.5 7% 3,195 1,753 2,320 629 219 473 7,792
Sealed Air (SEE) 6,537 32% 13.4 7% 5,216 5,558 4,720 1,508 370 718 9,606
Versum Materials (VSM) 5,704 42% 20.8 6% 1,459 1,255 1,341 569 86 309 6,416
WR Grace (GRA) 5,061 40% 16.0 5% 3,726 3,339 1,998 796 186 430 6,861
NewMarket (NEU) 4,509 28% 11.9 15% 1,767 1,178 2,202 606 258 429 5,114
Huntsman (HUN) 4,457 20% 14.9 -1% 8,896 6,220 8,908 1,761 -74 470 6,986
Chemours (CC) 4,249 25% 6.6 8% 7,433 6,604 5,876 1,496 607 1,184 7,868
Ingevity (NGVT) 4,073 37% 19.1 8% 2,130 1,729 1,219 448 173 283 5,412
Valvoline (VVV) 3,610 34% 17.0 11% 2,000 2,252 2,355 796 226 284 4,814
Olin (OLN) 3,566 15% 5.7 3% 9,235 6,464 6,654 1,010 270 1,212 6,855
Balchem (BCPC) 3,264 32% 21.4 7% 1,098 366 637 202 78 150 3,223
Sensient Technologies (SXT) 3,037 0% 14.8 8% 1,825 928 1,359 0 147 247 3,664
Rogers (ROG) 2,945 35% 16.8 7% 1,307 410 932 329 97 177 2,968
Platform Specialty Products (PAH) 2,714 43% -10.7 -9% 4,440 2,209 1,883 803 -395 -377 4,040

Balance Sheet ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash77162159771231107964283162
Accounts Receivable2,370
Inventory3503484706766886368007049921,097
PP&E9649189871,1361,2481,3081,0161,0021,0251,033
Assets3,1363,3203,7444,3745,2355,3406,3266,1399,2069,974
Accounts Payable290389458443475434404355714868
Long-Term Debt6106197999141,1891,1552,0381,8013,0942,565
Liabilities2,0602,1882,5032,8943,7153,8104,4604,1826,5246,853
Stockholders' Equity1,0761,1321,2411,4801,5201,5301,8661,9582,6823,121
Income Statement ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue2,8263,1163,3783,7483,8754,0383,2763,2822,8794,728
Cost of Revenue1,9442,0662,2102,4072,5342,6632,2012,0831,7772,641
Gross Profit8831,0511,1671,3411,3401,3751,0751,2001,1012,087
R&D93100105118118128144142142292
SG&A322411442527516621738530619851
Tax53132136147149109340633389
Net Income239185382436308322498212538512
Cash Flow ($MM)2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating344400426410379419-277537314446
Cash Investing-201-154-358-394-628-234-1,286-139-1,350-116
Cash Financing-78-117-25-48371-350-17-3771,213-363